Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ocera Therapeutics (OCRX)

Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ocera Therapeutics 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065 USA

www.ocerainc.com P: 650-475-0158

Description:

Ocera Therapeutics, Inc. is a biopharmaceutical company. It focused on the development and commercialization of proprietary compounds to treat acute and chronic orphan liver diseases. Ocera Therapeutics, Inc., formerly known as Tranzyme, Inc., is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 47,453
Shares Outstanding, K 26,510
Annual Sales, $ 610 K
Annual Net Income, $ -26,900 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,270 K
60-Month Beta 2.46
% of Insider Shareholders 7.24%
% of Institutional Shareholders 17.69%

Growth:

1-Year Return -20.44%
3-Year Return -70.66%
5-Year Return -79.84%
5-Year Revenue Growth -94.00%
5-Year Earnings Growth -91.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/22/17
Earnings Per Share ttm -0.97
EPS Growth vs. Prev Qtr -4.35%
EPS Growth vs. Prev Year 25.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 07/16/13

OCRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -228.93%
Return-on-Assets % -103.71%
Profit Margin % -4,409.84%
Debt/Equity 0.00
Price/Sales 77.06
Price/Cash Flow N/A
Price/Book 12.36
Book Value/Share 0.15
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar